Fugui Therapeutics Inc

Obesity Medicine in Palo Alto, California

Practice Details

Address
3926 Park Blvd
Palo Alto, CA 94306
Geocoded location: 37.4193, -122.1273
Taxonomy
Obesity Medicine (Preventive Medicine)
NPPES Enumeration
Listed with NPPES since 2021
Registered Contact
JUSAN YANG, PRESIDENT
NPPES Record Updated
July 2021

About This Practice

This practice is enumerated under Obesity Medicine, a Preventive Medicine subspecialty focused specifically on the medical management of obesity — including behavioral counseling, nutrition, and pharmacotherapy such as GLP-1 receptor agonists. Obesity-medicine specialists in Palo Alto are among the practices most likely to actively manage GLP-1 prescribing, though this registry entry does not confirm current prescribing practices.

Locally, this is 1 of 3 Obesity Medicine (Preventive Medicine) practices in Palo Alto carrying this exact taxonomy in our directory.

What to expect at an Obesity Medicine visit

A first visit at an obesity-medicine practice generally centers on a medical work-up rather than a quick prescription. In broad terms, patients often encounter:

  • A weight and health history, BMI/body-composition review, and discussion of prior weight-loss attempts.
  • A conversation about treatment options — lifestyle changes, and where appropriate anti-obesity medications such as GLP-1 receptor agonists (semaglutide, tirzepatide).
  • Baseline labs (e.g. A1c, metabolic panel, lipids) to screen for diabetes and metabolic conditions before starting medication.
  • A cost and coverage discussion, since many commercial plans limit obesity-only GLP-1 coverage and may require prior authorization.

This is general guidance for obesity medicine practices, not a description of Fugui Therapeutics Inc's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 650-400-1089.

GLP-1 access in Palo Alto, California

Adult obesity rate
28.1%
#44 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$219/mo
Typical California telehealth cash price
Medicaid GLP-1 coverage
Diabetes + obesity (with prior auth)
California Medicaid, obesity indication

About 28.1% of California adults have obesity (BMI 30+), ranking the state #44 of 50 (CDC BRFSS). Our directory currently lists 24 GLP-1-relevant clinics in Palo Alto. If a cash-pay route makes more sense, compounded semaglutide through California telehealth averages about $219/mo — well below brand-name Wegovy or Zepbound.

Explore more California options on the best California GLP-1 providers page, browse every Palo Alto listing in the Palo Alto clinic directory.

Related Practices in Palo Alto

Other Palo Alto listings in the same directory tier:

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to California addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured California telehealth partners:

Featured Partners · Palo Alto

Featured GLP-1 providers serving Palo Alto

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick

    Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  2. Compounded from

    $179/mo

    Save $1,170/mo vs Wegovy
    Get started →
  3. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  4. Compounded from

    $146/mo

    Save $1,203/mo vs Wegovy
    Get started →
  5. Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  6. Compounded from

    $112/mo

    Save $1,237/mo vs Wegovy
    Get started →

See more Palo Alto options on the Palo Alto clinic directory, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Palo Alto obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Fugui Therapeutics Inc's specialty taxonomy but not the specific medications it prescribes or its current service menu. Fugui Therapeutics Inc is listed under Obesity Medicine, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 650-400-1089 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Fugui Therapeutics Inc's primary specialty on file is Obesity Medicine.
Fugui Therapeutics Inc is located at 3926 Park Blvd, Palo Alto, CA 94306. The phone number listed in the registry is 650-400-1089. Its full record is public in the CMS National Provider registry under NPI 1699346346.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Fugui Therapeutics Inc is currently accepting new patients. Call the practice at 650-400-1089 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.